BRYNJELSEN SEAN

CIK 00016699762 companiesDEERPARK, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001669976

Recent Transactions

33 trades

Sale
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2026-05-28$32.67/sh−148→ 833,694 total
Sale
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2026-05-28$31.88/sh−119,852→ 833,842 total
Award
Eton Pharmaceuticals, Inc.$ETON
Restricted Stock Units
2026-01-12+100,517→ 3,147,829 total
Award
Eton Pharmaceuticals, Inc.$ETON
Employee Stock Option (Right to Buy)
2026-01-12+158,046→ 3,047,312 total
Tax Payment
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2026-01-01$15.39/sh−5,015→ 2,889,266 total
Tax Payment
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2025-12-12$16.83/sh−6,732→ 2,894,281 total
Sale
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2025-06-05$16.81/sh−70,000→ 2,873,513 total
Sale
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2025-06-04$17.00/sh−70,000→ 2,943,513 total
Sale
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2025-06-03$18.38/sh−8,655→ 3,013,913 total
Sale
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2025-06-03$17.38/sh−60,945→ 3,022,568 total
Sale
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2025-06-03$19.02/sh−400→ 3,013,513 total
Award
Eton Pharmaceuticals, Inc.$ETON
Restricted Stock Units
2025-01-03+72,004→ 72,004 total
Award
Eton Pharmaceuticals, Inc.$ETON
Employee Stock Option (Right to Buy)
2025-01-03+107,469→ 107,469 total
Award
Eton Pharmaceuticals, Inc.$ETON
Stock Option (Right to buy)
2024-02-13+438,633→ 2,473,014 total
Award
Eton Pharmaceuticals, Inc.$ETON
Stock Option (Right to buy)
2023-03-03+350,381→ 1,951,881 total
Purchase
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2022-09-22$2.10/sh+10,000→ 1,040,000 total
Award
Eton Pharmaceuticals, Inc.$ETON
Restricted Stock Units
2022-07-12+110,000→ 110,000 total
Award
Eton Pharmaceuticals, Inc.$ETON
Stock Option(Right to buy)
2022-02-07+416,500→ 1,601,500 total
Purchase
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2021-08-20$4.32/sh+10,000→ 1,030,000 total
Purchase
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2021-06-03$5.96/sh+5,000→ 1,030,000 total
Award
Eton Pharmaceuticals, Inc.$ETON
Stock Option(Right to buy)
2021-05-03+245,000→ 1,185,000 total
Award
Eton Pharmaceuticals, Inc.$ETON
Stock Option (Right to buy)
2020-03-12+490,000→ 490,000 total
Purchase
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2019-08-13$6.15/sh+5,000→ 1,025,000 total
Purchase
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2019-05-21$7.96/sh+8,600→ 1,020,000 total
Purchase
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2019-05-20$7.78/sh+1,400→ 1,011,400 total
Award
Eton Pharmaceuticals, Inc.$ETON
Stock option (right to buy)
2019-02-20+250,000→ 250,000 total
Conversion
Eton Pharmaceuticals, Inc.$ETON
Series A Convertible Preferred Stock
2018-11-15−23,000→ 0 total
Conversion
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2018-11-15+24,940→ 24,940 total
Purchase
Eton Pharmaceuticals, Inc.$ETON
Common Stock
2018-11-15$6.00/sh+10,000→ 1,010,000 total
Disposition to Issuer
Sagent Pharmaceuticals, Inc.
Stock Option to Buy
2016-08-29$9.56/sh−21,016→ 0 total
Disposition to Issuer
Sagent Pharmaceuticals, Inc.
Common Stock
2016-08-29$21.75/sh−9,844→ 0 total
Award
Sagent Pharmaceuticals, Inc.
Common Stock
2016-04-04+9,844→ 9,844 total
Award
Sagent Pharmaceuticals, Inc.
Stock Option to Buy
2016-04-04+21,016→ 21,016 total

Companies

Recent Filings

Address

C/O ETON PHARMACEUTICALS, INC. 21925 W. FIELD PARKWAY, SUITE 235

DEERPARK, IL, 60010-7208

View on SEC.gov